Loading clinical trials...
Loading clinical trials...
Metformin Chemoprevention of Oral Premalignant Lesions
Conditions
Interventions
Metformin
Biopsy
Locations
1
United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Start Date
May 4, 2022
Primary Completion Date
March 16, 2024
Completion Date
March 16, 2024
Last Updated
May 15, 2025
NCT06736379
NCT07331935
NCT05727761
NCT06321003
NCT05323292
NCT05075980
Lead Sponsor
Thomas Jefferson University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions